Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C14H15F2N3S.ClH |
| Molecular Weight | 331.812 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.NCC1=CNC(=S)N1[C@H]2CCC3=C(C2)C=C(F)C=C3F
InChI
InChIKey=DIPDUAJWNBEVOY-PPHPATTJSA-N
InChI=1S/C14H15F2N3S.ClH/c15-9-3-8-4-10(1-2-12(8)13(16)5-9)19-11(6-17)7-18-14(19)20;/h3,5,7,10H,1-2,4,6,17H2,(H,18,20);1H/t10-;/m0./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C14H15F2N3S |
| Molecular Weight | 295.351 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 1 / 1 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25602710
https://www.ncbi.nlm.nih.gov/pubmed/24983834
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/25602710
https://www.ncbi.nlm.nih.gov/pubmed/24983834
Nepicastat (SYN-117) is a potent and selective inhibitor of dopamine-β-hydroxylase. This compound in Phase 2 of clinical trial for the treatment cocaine addiction and posttraumatic stress disorder.
Originator
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
160 mg 1 times / day multiple, oral Dose: 160 mg, 1 times / day Route: oral Route: multiple Dose: 160 mg, 1 times / day Co-administed with:: сocaine Sources: Page: p.8 |
unhealthy, ADULT n = 13 Health Status: unhealthy Condition: cocaine abuse Age Group: ADULT Sex: M+F Food Status: UNKNOWN Population Size: 13 Sources: Page: p.8 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase. | 1997 Aug |
|
| Synthesis and biological evaluation of novel, peripherally selective chromanyl imidazolethione-based inhibitors of dopamine beta-hydroxylase. | 2006 Feb 9 |
|
| Effects of disulfiram and dopamine beta-hydroxylase knockout on cocaine-induced seizures. | 2008 Jun |
|
| Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine β-hydroxylase. | 2010 Nov |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: https://clinicaltrials.gov/ct2/show/NCT01704196?term=NEPICASTAT&rank=3
Post Traumatic Stress Disorder: 120 mg/day
Cocaine Dependence: Nepicastat 120 mg and 100 mg riboflavin (once per day) for 11 weeks
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 05:01:11 GMT 2023
by
admin
on
Sat Dec 16 05:01:11 GMT 2023
|
| Record UNII |
3WK068D17I
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
9840545
Created by
admin on Sat Dec 16 05:01:11 GMT 2023 , Edited by admin on Sat Dec 16 05:01:11 GMT 2023
|
PRIMARY | |||
|
DTXSID00168811
Created by
admin on Sat Dec 16 05:01:11 GMT 2023 , Edited by admin on Sat Dec 16 05:01:11 GMT 2023
|
PRIMARY | |||
|
3WK068D17I
Created by
admin on Sat Dec 16 05:01:11 GMT 2023 , Edited by admin on Sat Dec 16 05:01:11 GMT 2023
|
PRIMARY | |||
|
170151-24-3
Created by
admin on Sat Dec 16 05:01:11 GMT 2023 , Edited by admin on Sat Dec 16 05:01:11 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
